Home » Stocks » NMRD

Nemaura Medical Inc. (NMRD)

Stock Price: $4.26 USD 0.00 (0.00%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 97.59M
Revenue (ttm) n/a
Net Income (ttm) -4.47M
Shares Out 22.91M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $4.26
Previous Close $4.26
Change ($) 0.00
Change (%) 0.00%
Day's Open 4.24
Day's Range 4.17 - 4.28
Day's Volume 8,100
52-Week Range 2.50 - 16.50

More Stats

Market Cap 97.59M
Enterprise Value 85.86M
Earnings Date (est) Feb 5, 2021
Ex-Dividend Date n/a
Shares Outstanding 22.91M
Float 8.77M
EPS (basic) -0.20
EPS (diluted) -0.21
FCF / Share -0.21
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 96,268
Short Ratio 3.35
Short % of Float 1.10%
Beta -0.51
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 8.44
Revenue n/a
Operating Income -4.55M
Net Income -4.47M
Free Cash Flow -4.68M
Net Cash 11.73M
Net Cash / Share 0.51
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -27.30%
ROE -78.21%
ROIC -282.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$14.00*
Low
14.0
Current: $4.26
High
14.0
Target: 14.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue--------
Operating Income-4.78-4.48-1.91-1.55-1.54-1.32-0.59-0.83
Net Income-4.16-4.45-1.82-1.55-1.54-1.32-0.59-0.83
Shares Outstanding20.8118.0915.0120.5020.1720.0018.5318.00
Earnings Per Share-0.20-0.25-0.10---0.10--
Operating Cash Flow-3.45-3.56-2.14-1.19-1.21-1.431.50-0.77
Capital Expenditures-0.21-0.08-0.05-0.08-0.01-0.02--0.03
Free Cash Flow-3.66-3.64-2.18-1.27-1.22-1.451.50-0.80
Cash & Equivalents0.113.745.737.149.400.351.960.20
Net Cash / Debt0.113.745.737.149.400.351.960.20
Assets1.224.766.267.409.730.912.050.26
Liabilities2.532.542.142.042.051.831.68-
Book Value-1.312.234.115.377.68-0.920.370.26
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Nemaura Medical Inc.
Country United States
Employees 17
CEO Dewan Fazlul Hoque Chowdhury

Stock Information

Ticker Symbol NMRD
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: NMRD

Description

Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; the Why WAIT app; and common law trademarks which incorporate the mark WHY WAIT or WHYWAIT and the use of licensed marks. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.